Abbott Laboratories
ABT Healthcare Medical Devices
Abbott Laboratories' revenue for fiscal 2025 (year ended December 2025) was $44.3 billion, up 5.67% from fiscal 2024. In the quarter to June 2026, revenue grew 13.0%, EPS fell 47.5%, free cash flow grew 28.9% and total debt rose 142.7%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years; insiders bought in the last twelve months.
Follow ABT
Abbott Laboratories (ABT) Free cash flow margin
Abbott Laboratories's free cash flow margin over the twelve months to 30 June 2026 was 16.8%, up 0.1 percentage points from fiscal 2025 (16.7%). Over the past ten years it has ranged from 9.10% (fiscal 2015) to 20.1% (fiscal 2021); the current reading is higher than 82% of that period. That is above the Medical Devices industry median of −7.24% and above the Healthcare sector median of 0.00%.
Free cash flow margin, annual
Embed this chart
Annual newest first
| Period | Free cash flow margin | Change (points) |
|---|---|---|
| FY2025 | 16.7% | 1.54 |
| FY2024 | 15.1% | 2.53 |
| FY2023 | 12.6% | (5.27) |
| FY2022 | 17.9% | (2.20) |
| FY2021 | 20.1% | 3.54 |
| FY2020 | 16.5% | 2.44 |
| FY2019 | 14.1% | (1.94) |
| FY2018 | 16.0% | (0.15) |
| FY2017 | 16.2% | 6.21 |
| FY2016 | 9.98% | 0.88 |
Against its own ten years
Free cash flow margin against peers
| Company | Free cash flow margin |
|---|---|
| DXCM DexCom, Inc. compare | 28.3% |
| EW Edwards Lifesciences Corporation compare | 22.0% |
| SYK Stryker Corporation compare | 18.2% |
| BSX Boston Scientific Corporation compare | 17.3% |
| ABT Abbott Laboratories | 16.8% |
| MDT Medtronic PLC compare | 16.3% |
| STE STERIS plc compare | 15.5% |
| PHG Koninklijke Philips N.V. compare | 8.99% |
| GEHC GE HealthCare Technologies Inc. compare | 7.42% |
| Medical Devices industry median | −7.24% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Free cash flow margin is
Free Cash Flow Margin tells an investor how much of each sale turns into cash the company keeps after paying for investment in its assets.
(Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)) ÷ Revenue
More on ABT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement